267 related articles for article (PubMed ID: 15848051)
1. Pharmacokinetics of an immediate release, a controlled release and a two pulse dosage form in dogs.
Löbenberg R; Kim JS; Amidon GL
Eur J Pharm Biopharm; 2005 May; 60(1):17-23. PubMed ID: 15848051
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic evaluation of guar gum-based three-layer matrix tablets for oral controlled delivery of highly soluble metoprolol tartrate as a model drug.
Al-Saidan SM; Krishnaiah YS; Satyanarayana V; Bhaskar P; Karthikeyan RS
Eur J Pharm Biopharm; 2004 Nov; 58(3):697-703. PubMed ID: 15451547
[TBL] [Abstract][Full Text] [Related]
3. Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans.
Tubic M; Wagner D; Spahn-Langguth H; Weiler C; Wanitschke R; Böcher WO; Langguth P
Eur J Pharm Sci; 2006 Nov; 29(3-4):231-9. PubMed ID: 16713700
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride.
Feng XM; Ren Q; Zhang WZ; Shen HF; Rong ZX; Fang C; Chen HZ
J Pharm Pharmacol; 2008 Jul; 60(7):817-22. PubMed ID: 18549667
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
6. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.
Kuentz M; Nick S; Parrott N; Röthlisberger D
Eur J Pharm Sci; 2006 Jan; 27(1):91-9. PubMed ID: 16219449
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics of triptolide in Beagle dogs].
Shao F; Wang GJ; Sun JG; Xie HT; Zhang R; Zhu XY
Yao Xue Xue Bao; 2007 Jan; 42(1):61-5. PubMed ID: 17520809
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical and preclinical pharmacokinetic and toxicological evaluation of LK-423--a new phthalimido-desmuramyl-dipeptide derivative with immunomodulating activity.
Smrdel P; Grabnar I; Locatelli I; Cerne M; Andrensek S; Kovacic N; Kristl A; Bogataj M; Urleb U; Mrhar A
Drug Dev Ind Pharm; 2009 Nov; 35(11):1293-304. PubMed ID: 19832629
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of ursodeoxycholic acid bioavailability from immediate- and sustained-release preparations using gas chromatography-mass spectrometry and high-performance liquid chromatography.
Scalia S; Scagliarini R; Pazzi P
Arzneimittelforschung; 2000 Feb; 50(2):129-34. PubMed ID: 10719615
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics in dogs after oral administration of two different forms of ascorbic acid.
Wang S; Berge GE; Hoem NO; Sund RB
Res Vet Sci; 2001 Aug; 71(1):27-32. PubMed ID: 11666144
[TBL] [Abstract][Full Text] [Related]
11. Development of an oral sustained release drug delivery system utilizing pH-dependent swelling of carboxyvinyl polymer.
Nakamura K; Nara E; Akiyama Y
J Control Release; 2006 Apr; 111(3):309-15. PubMed ID: 16473430
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and bioavailability of diltiazem (CRD-401) in dog.
Kohno K; Takeuchi Y; Etoh A; Noda K
Arzneimittelforschung; 1977 Jul; 27(7):1424-8. PubMed ID: 578467
[TBL] [Abstract][Full Text] [Related]
14. Biopharmaceutic approach in designing a controlled release tablet of sodium monofluoro phosphate. Characterization of absorption sites and evaluation of modified dosage form.
Vattikonda CS; Ritschel WA; Herbert C
Int J Clin Pharmacol Ther; 1994 Oct; 32(10):559-66. PubMed ID: 7834164
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of an immediate and extended release oral morphine formulation utilizing the spheroidal oral drug absorption system in dogs.
Aragon CL; Read MR; Gaynor JS; Barnhart MD; Wilson D; Papich MG
J Vet Pharmacol Ther; 2009 Apr; 32(2):129-36. PubMed ID: 19290942
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates.
Kortejärvi H; Urtti A; Yliperttula M
Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967
[TBL] [Abstract][Full Text] [Related]
17. Distribution of metoprolol in human autopsy material.
Oertel R; Pietsch J; Arenz N; Goltz L; Kirch W
Pharmazie; 2011 Feb; 66(2):115-8. PubMed ID: 21434573
[TBL] [Abstract][Full Text] [Related]
18. The bioavailability of two beta-blockers preadsorbed onto charcoal.
Roivas L; Ojala-Karlsson P; Neuvonen PJ
Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):125-32. PubMed ID: 7911863
[TBL] [Abstract][Full Text] [Related]
19. Pulsatile multiparticulate drug delivery system for metoprolol succinate.
Jagdale SC; Chede SM; Gulwady R; Kuchekar BS; Lokhande PD; Shah TP; Chabukswar AR
Arch Pharm Res; 2011 Mar; 34(3):369-76. PubMed ID: 21547667
[TBL] [Abstract][Full Text] [Related]
20. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]